<Emphasis Type="Bold">Background: Attempts to estimate the cost effectiveness of attention-deficit hyperactivity disorder (ADHD) treatments in the past have relied on classifying <Emphasis Type="Bold">ADHD patients as responders or non-responders to treatment. Responder status has been associated with a small gain in health-related...</emphasis></emphasis>

Currently, health state values are usually obtained from members of the general public trying to imagine what the state would be like rather than by patients who are actually in the various states of health. Valuations of a health state by patients tend to vary from those of the general...

The introduction of competition between health care providers in the NHS has been advocated as a means of promoting efficiency. In this paper we review one model of competition, internal markets, in which health authorities would be able formally to contract to buy and sell clinical services...

Recently the National Institute for Clinical Excellence (NICE) updated its methods guidance for technology assessment. One aspect of the new guidance is to require the use of probabilistic sensitivity analysis with all cost-effectiveness models submitted to the Institute. The purpose of this...

Brouwer and colleagues &lsqb;1&rsqb; argue that the reasons for specifying an equal discount rate for health outcomes and costs in the recent guidance on methods of technology appraisal issued by the National Institute for Clinical Excellence (NICE) &lsqb;2&rsqb; is both opaque and wrong. They argue that a lower...

Background:Background: Attempts to estimate the cost effectiveness of attention-deficit hyperactivity disorder (ADHD) treatments in the past have relied on classifying ADHD patients as responders or non-responders to treatment. Responder status has been associated with a small gain in...